Introduction
Due to their multifunctional properties, including a small size effect, superparamagnetism, and inherent biocompatibility, magnetic nanoparticles are being used increasingly for medical diagnosis and therapy, and especially for biomedical and biotechnology applications, including targeted drug delivery systems, contrast agents for magnetic resonance imaging, and hyperthermia for tumor therapy. [1] [2] [3] In cell biology research, superparamagnetic iron oxide (SPIO) particles can be used for cell labeling, cell sorting, separation, and purification procedures. [4] [5] [6] [7] Although they are very promising for in vivo application in imaging and drug delivery, there has been concern about their biological safety, so their use has been restricted.
Dendritic cells are major antigen-presenting cells in the initiation and development of adaptive immune responses against bacteria, viruses, allergens, and tumor antigens. Essentially, dendritic cells induce potent immune responses via their ability to migrate from the periphery via afferent lymphatics to areas containing T cells in secondary lymphoid organs.
Immature dendritic cells residing in peripheral tissues monitor the microenvironment, and mature when starting to take up different antigens. During maturation, immature dendritic cells alter surface molecules, decreasing phagocytic ability, and strengthening their ability to migrate to lymph nodes, where they activate naive T cells via major histocompatibility complex (MHC) and costimulatory molecules. [9] [10] [11] However, clinical studies of the ability of a dendritic cell vaccine to induce immunity against tumors did not demonstrate effective antitumor immunity. 12, 13 Because the responses of dendritic cell vaccine were not stable in clinical trials, monitoring of the injected cells may be important. Because of its ability to provide additional anatomical information and more detailed visualization, magnetic resonance imaging (MRI) may be an useful method for detecting labeled cells. The purpose of this study was to establish an efficient labeling method for dendritic cells in mouse bone marrow and to assess the influence of synthesized SPIO on dendritic cells for tracking them in vivo by MRI in the future.
Materials and methods Materials
Ferric chloride (FeCl 3 · 6H 2 O), ferrous sulfate (FeSO 4 · 7H 2 O), and hydrochloric acid (30%) were purchased from Sinopharm Chemical Reagent Co Ltd, Shanghai, China. Tetramethylammonium hydroxide was from Shanghai Lingfeng Chemical Reagent Co Ltd, Shanghai, China. Other materials were RPMI 1640 medium, penicillin, and streptomycin (Gibco-Invitrogen, Grand Island, NY), fetal bovine serum (Gibco, Life Technologies, Breda, the Netherlands), recombinant murine granulocyte-macrophage colony-stimulating factor, recombinant murine interleukin-4, CD11c, B7-1 (CD80), B7-2(CD86), MHC II, and chemokine receptor 7 (eBioscience, San Diego, CA), tumor necrosis factor-α, interleukin-1β, and interleukin-6 (Peprotech, Rocky Hills, NJ), prostaglandin E2 (Sigma-Aldrich, St Louis, MO), a Prussian blue staining kit (Shanghai Yuanye BioTechnology Co Ltd, China). Annexin V and propidium iodide (Biouniquer, Biostar, China), and the Cell Counting Kit-8 (Dojindo, Japan).
Preparation of sPIO
γ-Fe 2 O 3 nanoparticles were prepared according to a method we have described previously.
14 Briefly, 200 mL of aqueous tetramethylammonium hydroxide 1.5 M solution was added to a 500 mL aqueous solution containing FeCl 3 0.1 M and FeSO 4 0.05 M with vigorous stirring at room temperature for 30 minutes. The resulting Fe 3 O 4 nanoparticles were washed by magnetic separation and redispersed in water at pH 3.0 and a concentration of 3 mg/mL, then oxidized into brown γ-Fe 2 O 3 nanoparticles by aeration at 95°C. The γ-Fe 2 O 3 nanoparticles obtained were dialyzed using an aqueous solution of hydrochloric acid at pH 3.0, and the final concentration was adjusted to 25 mg/mL for the cell labeling experiments.
The particle size and morphology of the γ-Fe 2 O 3 nanoparticles obtained was characterized by transmission electronic microscopy (JEOL JEM-2100). The magnetic properties were measured by a vibrating sample magnetometer (Lakeshore 7407). Photon correlation spectroscopy was used to determine the hydrodynamic size distribution using an N4 Plus submicron particle analyzer (Beckman Coulter, Indianapolis, IN), and surface charge measurements were performed using a Delsa 440SX zeta potential analyzer (Beckman Coulter).
Mice
Female BALB/c and C57BL/6 mice were purchased from the Animal Research Center of Yangzhou University, People's Republic of China, and kept under pathogen-free conditions in the central animal facility at Nanjing University. In a typical experiment, bone marrow was isolated from the femurs of 8-10-week-old mice weighing from 20-22 g. All animal experiments were performed in accordance with protocols approved by the animal care and use committee of the Medical School, Nanjing University, China.
cell culture
Monocytes were isolated from mouse bone marrow. Marrow monocytes were flushed out from the femurs and tibias of the mice, cultured with RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 mg/mL streptomycin, 10 ng/mL recombinant murine granulocytemacrophage colony-stimulating factor, and 1 ng/mL recombinant murine interleukin-4. 15 On days 2 and 4, 50% of the medium was removed and fresh media was added. The released immature, nonadherent dendritic cells were collected on day 6. The cells were stimulated with 10 ng/mL tumor necrosis factor-α, 10 ng/mL interleukin-1β, 10 ng/mL interleukin-6, and 1 µg/mL prostaglandin E2 for 48 hours. 16, 17 The mature dendritic cells were collected on day 8.
cell labeling and Prussian blue staining
Immature and mature dendritic cells were incubated with SPIO 25 µg/mL for 12 hours at 37°C in 5% CO 2 . Cells were washed three times in phosphate-buffered solution superparamagnetic iron oxide and dendritic cells and cytospins were prepared. Iron labeling efficiency was verified by Prussian blue staining. Labeled dendritic cells on cytospins were fixed with 4% paraformaldehyde for 30 minutes at room temperature, washed, and incubated with 2% potassium ferrocyanide in 2% hydrochloric acid for 30 minutes, and washed again. Screenings were performed at high magnification (×400) using a light microscope (Olympus, CKX41-A32PH, Japan).
Flow cytometry
For phenotypic analysis, both labeled and unlabeled dendritic cells were harvested, washed thoroughly, individually stained with allophycocyanin-conjugated monoclonal antibodies specific for CD11c, fluorescein isothiocyanate-conjugated for MHC-II, phycoerythrin-conjugated for CD80, CD86, and chemokine receptor 7, according to the manufacturer's instructions, and studied by flow cytometry (Calibur, Becton Dickinson, San Antonio, TX). Meanwhile, apoptosis rates were measured. Briefly, cells labeled or unlabeled with SPIO were collected, and stained with Annexin V and propidium iodide. After being washed, the apoptotic cells were studied by flow cytometry and analyzed using Cell Quest software.
cellular uptake of sPIO
The SPIO uptake by dendritic cells was assessed according to the method described by Ge et al. 18 Briefly, immature and mature dendritic cells were collected, washed with phosphate-buffered saline, and resuspended in 30% HCl (v/v) at 60°C for two hours. Potassic persulfate 1.0 mg was then added to oxidize the ferrous ions in the above solution to ferric ions. Potassium thiocyanate 0.1 M 1.0 mL was added to form the iron-thiocyanate complex. A 150 µL quantity of the mixture was transferred to a flat-bottomed 96-well plate (Corning Costar, Cambridge, MA). The absorbance was measured at 480 nm using a microplate reader 10 minutes later (Bio-Tek Instruments Inc, Winooski, CT). A standard curve of an aqueous FeCl 3 · 6H 2 O solution was treated in the same manner to quantify the amount of SPIO uptake in the cells. The iron content of the SPIO-labeled dendritic cells was expressed as the amount of Fe 2 O 3 .
Mixed lymphocyte reaction assay
Dendritic cells labeled with SPIO were collected and washed. Purified CD4 + T cells were obtained by positive magnetic bead separation (Miltenyi Biotec, Boston, MA) from the lymph nodes (axillary, inguinal, mesenteric) of normal BALB/c mice. Allogeneic T cells were incubated with dendritic cells or SPIO-labeled dendritic cells at ratios of 5:1, 10:1, 50:1, and 100:1 in flat-bottomed 96-well plates. After incubation for three days, cell activation and proliferation was evaluated using a Cell Counting Kit-8, and the absorbances were read at 450 nm using the microplate reader according to the manufacturer's instructions.
statistical analysis
Data were analyzed using the Statistical Package for Social Science (version 13.0, SPSS Inc, Chicago, IL). Results were expressed as means ± standard deviation, and differences between control and test groups were assessed by one-way analysis of variance and two-tailed Student's t-test. The level of statistical significance was set at P , 0.05.
Results

characterization of sPIO
Under transmission electron microscopy, γ-Fe 2 O 3 nanoparticles were measured at an average diameter around 8.7 nm, and were seen as nearly spherical shapes ( Figure 1A) . A vibrating sample magnetometer demonstrated that the γ-Fe 2 O 3 nanoparticles obtained possessed superparamagnetic behavior, with saturation magnetization of 60.4 emu/g ( Figure 1B ). The average hydrodynamic size of the γ-Fe 2 O 3 nanoparticles in water was 92 nm, and the zeta potential had a positive surface charge of 20.9 mV.
SPIO labeling efficiency and cell phenotypes
Prussian blue staining was performed to evaluate SPIO labeling efficiency. After 12 hours of incubation with SPIO at a concentration of 25 µg/mL, nearly all cells were shown to contain iron ( Figure 2 ). Before study of the phenotypic changes in labeled dendritic cells, the ratio of dendritic cells in the induced marrow monocytes was analyzed. The results indicated that 80% of the cells were CD11c + , which is regarded as a major marker for dendritic cells (Figure 3) .
To determine whether dendritic cell surfaces would be influenced by SPIO labeling, an immunostaining assay was performed with a panel of antibodies against the costimulatory molecules CD80, CD86, MHC-II, and chemokine receptor 7, followed by flow cytometry analysis. After being stimulated by tumor necrosis factor-α, interleukin-1β, interleukin-6, and prostaglandin E2, expression of CD80, CD86, MHC-II, and chemokine receptor 7 was significantly increased in mature dendritic cells compared with immature dendritic cells. Expression of these four markers in mature dendritic cells and mature SPIO-labeled dendritic cells was similar, with no statistically significant difference between the groups (P . 0.05). In contrast, compared with unlabeled cells, expression of CD80, CD86, and MHC-II on SPIO-labeled immature dendritic cells was upregulated, while chemokine receptor 7 remained at almost the same level ( Figure 4 ).
cell apoptosis
To test whether dendritic cells labeled with SPIO nanoparticles could have any influence on cell apoptosis, both mature dendritic cells and mature SPIO-labeled dendritic cells were analyzed by flow cytometry using Annexin V-propidium iodide methods at different time points (0, 6, 12, 24, and 36 hours). The results indicate no significant difference in cell apoptosis between mature dendritic cells and mature SPIO-labeled dendritic cells ( Figure 5 ). cellular uptake of sPIO SPIO particles internalized by dendritic cells were examined using a quantitative spectrophotometric method. There was a linear correlation (r 2 . 0.99) between absorbance and concentration of nanoparticles in culture medium. On average, the mean concentration of iron in immature SPIO-labeled dendritic cells and mature SPIO dendritic cells was 31.8 ± 0.7 µg and 35.6 ± 1.0 µg per 1 × 10 6 cells, respectively ( Figure 6 ).
Mixed lymphocyte reaction assay
The mixed lymphocyte reaction assay used to observe the functional properties of SPIO-labeled dendritic cells used ratios of dendritic cells to T cells of 1:5, 1:10, 1:50, and 1:100, respectively. Activation and proliferation of T cells was notably decreased as the ratios decreased from 1:5 to 1:100. Both mature SPIO-labeled and unlabeled dendritic cells showed a significant increase in T cell activation and proliferation when the ratio of dendritic cells to T cells was 1:5. Similar results were observed for immature dendritic cells and immature SPIO-labeled dendritic cells, but the absorbance of mature SPIO-labeled dendritic cells was lower than that of mature dendritic cells (P , 0.05). There was no significant difference detected at other ratios ( Figure 7 ). 
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Discussion
The basic criteria for the use of SPIO in bioscience are safety and biocompatibility, which are determined by size and superficial characteristics. Superparamagnetic Fe 3 O 4 nanoparticles have demonstrated good biocompatibility and safety when used as drug carriers and targeted tumor therapy. 19, 20 γ-Fe 2 O 3 nanoparticles with a positive surface charge were synthesized by oxidation and acidification from Fe 3 O 4 and had a good superparamagnetic behavior. The precursors were prepared according to a modified Massart method and reduction coprecipitation without argon protection. 21, 22 SPIO preparation was simple and feasible, and the characteristics of synthetic SPIO were proved to be suitable for biological application (Figure 1) .
Because the immune response of dendritic cell vaccines against solid tumors has often been shown to be weak or localized, there has been concern about the need to track migration of dendritic cells accurately in vivo. In this study, a novel approach to forming SPIO-labeled dendritic cells was introduced, and the influence of SPIO on dendritic cells was investigated. SPIO is an attractive contrast agent for cell migration. It is a biodegradable and feasible agent for study of living cells by MRI in vitro and in vivo. 14, 23 Due to the phagocytic properties and negative membrane potential of dendritic cells, SPIO-labeled nanoparticles could be easily delivered to the cells. 24 In our study, SPIO was internalized into dendritic cells, and this was confirmed by Prussian blue staining (Figure 2) .
Before evaluating the influence of SPIO-labeled dendritic cells, the dendritic cells were first identified. CD11c is widely regarded as a major marker for dendritic cells. In this study, flow cytometry indicated that 80% of bone marrow monocytes were CD11c + , showing this to be a reliable method for providing sufficient cells for further studies (Figure 3 ).
Phenotype and maturation of dendritic cells are critical factors which may be changed by SPIO labeling. In our study, after immature dendritic cells were labeled by SPIO, expression of CD80, CD86, and MHC II was found to be upregulated, while chemokine receptor 7 levels remained unchanged. We hypothesize that SPIO was engulfed as antigens by immature dendritic cells, which induced early 
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superparamagnetic iron oxide and dendritic cells maturation of these dendritic cells. Although MHC II was upregulated, there were no actual antigen formation via MHC II which could explain the unaltered expression of chemokine receptor 7. After stimulation by inflammatory cytokines, ie, tumor necrosis factor-α, interleukin-1β, interleukin-6, and prostaglandin E2, the expression of these four markers was increased significantly in both labeled and unlabeled mature dendritic cells. These findings suggested that SPIO had little influence on the phenotypes of mature dendritic cells (Figure 4) . Moreover, there was no significant change in apoptosis after SPIO labeling ( Figure 5) .
Furthermore, the concentration of intracellular iron in SPIO-labeled dendritic cells was measured. The optimal concentration and coculture time of SPIO for dendritic cell-labeling were 25 µg/mL and 12 hours, respectively, as shown in our previous study (data not shown). Cells containing iron were found to carry an average amount of 31.8 ± 0.7 µg per 1 × 10 6 cells in immature dendritic cells and 35.6 ± 1.0 µg per 1 × 10 6 cells in mature dendritic cells ( Figure 6 ). Verdijk et al 25 have shown that an average of 30 µg iron per 1 × 10 6 cells will not hinder cell viability, with the concentration of SPIO in their study set as 200 µg ferrum oxide/mL and a coculture time of 4 days. In contrast, this type of synthetic SPIO was shown to be more easily inserted, independent of concentration or coculture time, than suggested by previous reports. 25, 26 To confirm whether SPIO labeling could affect function and apoptosis of dendritic cells, the capacities of antigenprocessing, presenting, and naive allogeneic T cells stimulated by dendritic cells were tested by a mixed leukocyte reaction assay. The results showed that dendritic cells could maintain T cell activation and proliferation after being labeled by SPIO, except if the ratio of dendritic cells to T cells was 1:5, when the stimulating ability of mature dendritic cells was partly limited by SPIO. A similar phenomenon was not found for the other experimental groups (Figure 7) . Because the proportion of dendritic cells in the peripheral tissues was very low, the number of dendritic cells migrating from the periphery to the secondary lymphoid organs was estimated to be less than 10%, 8, 28 and the possibility of the ratio being restricted to 1:5 was almost impossible. Similar results have been obtained using other types of SPIO.
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Conclusion
From the data presented, SPIO has a negligible influence on dendritic cell function, especially mature dendritic cells. This study describes a novel approach for MRI investigation of dendritic cell migration. Hopefully, our work will serve as a useful method for evaluating activation of the immune response against tumor tissue by dendritic cell vaccines in the future.
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors. 
